Application 091616
- Type
- ANDA
- Sponsor
- GLENMARK GENERICS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | LITHIUM CARBONATE | LITHIUM CARBONATE | TABLET, EXTENDED RELEASE;ORAL | 450MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 42291-496 | Lithium Carbonate | Lithium Carbonate | AvKARE | ANDA | Current |
| 63629-7903 | Lithium Carbonate | Lithium Carbonate | Bryant Ranch Prepack | ANDA | Current |
| 63629-7903 | Lithium Carbonate | Lithium Carbonate | Bryant Ranch Prepack | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |
| 68462-224 | Lithium Carbonate | Lithium Carbonate | Glenmark Pharmaceuticals Inc., USA | ANDA | Current |